CAHE researchers are committed to healthcare solutions responsive to consumer needs globally.
CAHE researchers are committed to driving safe, effective and efficient healthcare solutions that are responsive to consumer needs globally. Our focus continues to be on making a vital contribution to the science of health economics and data sciences; strengthening our focus on evaluation of policies and interventions to maximise health outcomes; and developing and strengthening international and national collaborations.
As a reflection of the strength of the CAHE’s contribution, our research program was assessed in the 2018 Excellence in Research for Australia (ERA) evaluation as delivering high impact. CAHE’s research was ranked at world standard in the field of Applied Economics (1402), reflecting the volume of high-quality research undertaken by the team. Team members have close links to Griffith University's School of Medicine and Dentistry.
Improving Access and Outcomes for Podiatry Patients with Value Based Care
The Allied Health Professions’ Office Queensland recently commissioned the Centre to lead evaluations of several programs within their department. CAHE evaluated the financial implications for the Australian Government if prescriptions from endorsed podiatrists and podiatric surgeons were eligible for subsidy under the Pharmaceutical Benefits Scheme. The final report is aimed to inform policy makers about the impacts of this endorsement for the PBS : Budget Impact Assessment PBS Subsidies_Podiatry_report ( PDF 636k)
The cost-effectiveness of the Queensland Department of Health’s new recurrent funding initiative to incentivise improved access to diabetes-related foot disease service models was also evaluated by the Centre. Report findings: Diabetic Foot Disease_ Report (PDF 1.1MB)
Pharmaceutical Benefits Advisory Committee (PBAC) and Medical Services Advisory Committee (MSAC)
Members of CAHE are responsible for evaluating health technologies such as pharmaceuticals, medical services and diagnostic tests to inform Government decisions for funding under Medicare. The CAHE informed funding decisions amounting to $2.3bn in Government expenditure over the five-year period 2014-2018 leading to provision of cost-effective access of quality technologies to an estimated 10 million people. Research conducted by the Centre for the Department of Health therefore has a direct impact on health policy and financial decision making in Australia.
Post-market Review of biologics for severe chronic plaque psoriasis - Report to PBAC
The purpose of the project was to review the clinical guidelines, the effectiveness and the use of biologics on the PBS in severe chronic plaque psoriasis. It is expected that the findings from this research can be used to inform clinical practice, health policy, and Government subsidy decisions in responding to improving health outcomes associated with the management of severe psoriasis. The report produced by the Centre aims to advise Government on future financial investment requirements to expand subsidy to a larger group of patients. View the draft report for free on the PBS website.
Economic evaluation of the Gold Coast University Hospital Integrated Care (GCIC) program
CAHE led an evaluation on the Gold Coast Integrated Care program, with support funding from the Department of Health, to determine the effectiveness and costs of a new model of care. The Gold Coast Integrated Care program, based at the Gold Coast Hospital and Health Service, aims to manage high-risk patients with complex and chronic conditions proactively. In collaboration with general practitioners, the program also aims to provide effective disease management and reduce potentially preventable hospitalisations. A final report to the Department of Health has been submitted for consideration.
Our research
CAHE has close links with School of Medicine and Dentistry, where you can discover more about our colleagues and collaborators, about our strategic approaches and, innovation and collaboration across our six key focus areas, including: Economic evaluation of healthcare interventions and programs; Measuring consumer preferences for healthcare interventions and services; Valuing health and healthcare; Health technology assessment; Health services research; and Biostatistics.
Get in touch
Contact the Centre for Applied Health Economics on (07) 3735 - 9117